While there are currently no studies on the interaction between the targets of celastrol, we have hypothesized that celastrol may also play an anti-tumor role by reducing the binding of HSP90 to STAT3 and reducing STAT3 phosphorylation, and we will conduct experiments to verify our conjecture in the future. The gene discussed is STAT3; the disease is neoplasm.